|
|||||
![]() |
|
New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves
Chicago, IL – October 22, 2025 – Stocks in this week’s article are Flux Power Holdings Inc. FLUX, Aura Minerals Inc. AUGO, Arcturus Therapeutics Holdings Inc. ARCT and Sterling Infrastructure Inc. STRL.
U.S. stock markets have continued their northward journey in 2025 following an impressive rally over the past two years. A weak labor market has raised expectations that the Fed will continue to reduce the benchmark lending rate during the rest of 2025.
However, the recent shutdown of the U.S. government and consequent delay of the release of several key economic data may drag down investors' enthusiasm. Moreover, trade and tariff-related serious conflicts between the United States and its major trading partner, China, dented market participants' sentiments.
Consequently, a few stocks have shown price strength. We have primarily targeted stocks that have recently been on a bull run. Such stocks have a high chance of carrying the momentum forward.
Four such stocks are — Flux Power Holdings Inc., Aura Minerals Inc., Arcturus Therapeutics Holdings Inc. and Sterling Infrastructure Inc..
If a stock is continuously witnessing an uptrend, there must be a solid reason or it would have probably crashed. So, looking at stocks capable of beating the benchmark that they have set for themselves seems rational.
However, recent price strength alone cannot create magic. Therefore, other relevant parameters are needed to create a successful investment strategy.
Here's how you should create the screen to shortlist the current as well as the potential winners.
Let's discuss those four stocks here:
Flux Power Holdings designs, develops and sells rechargeable energy storage systems. FLUX's primary product consists of the Flux Power 24-volt lithium pack and individual 3.2-volt cells. FLUX offers system accessories, such as stand-alone battery management, stackable chargers and programming software.
The stock price of Flux Power Holdings has soared 92.1% over the past four weeks. The company has an expected earnings growth rate of 82.4% for the current year (ending June 2026). The Zacks Consensus Estimate for current-year earnings has improved 40% over the past 60 days.
Aura Minerals is focused on the development and operation of gold and base metal projects principally in the Americas. AUGO operates through Minosa Mine, Apoena Mine, the Aranzazu Mine, Corporate, Almas Mine, and Borborema Projects segments. The company primarily explores gold, copper, and silver deposits.
The stock price of AUGO has climbed 9.3% over the past four weeks. It has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 2.5% over the past seven days.
Arcturus Therapeutics Holdings is a preclinical-stage biopharmaceutical company. ARCT focuses on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system LUNAR and UNA Oligomer chemistry technologies.
The stock price of ARCT has advanced 2.3% over the past four weeks. It has an expected earnings growth rate of -10% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 11.5% over the past 90 days.
Sterling Infrastructure operates through subsidiaries within segments specializing in E-Infrastructure, Building and Transportation Solutions principally in the United States, primarily across the Southern, Northeastern, Mid-Atlantic and the Rocky Mountain States, California and Hawaii.
STRL's E-Infrastructure Solutions projects develop advanced, large-scale site development systems and services for data centers, e-commerce distribution centers, warehousing, transportation, energy and more. STRL's Building Solutions projects include residential and commercial concrete foundations for single-family and multi-family homes, parking structures, elevated slabs and other concrete work. STRL's Transportation Solutions includes infrastructure and rehabilitation projects for highways, roads, bridges, airports, ports, light rail, water, wastewater and storm drainage systems.
The stock price of Sterling Infrastructure has gained 0.4% over the past four weeks. It has an expected earnings growth rate of 56.9% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 9.7% over the past 60 days.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2772945/4-stocks-with-recent-price-strength-to-maximize-your-gains
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Follow us on Twitter: https://www.twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: [email protected]
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
31 min |
Arcturus Crashes 60% On 'Underwhelming' Results For mRNA-Tied Cystic Fibrosis Drug
ARCT -57.94%
Investor's Business Daily
|
1 hour | |
3 hours | |
6 hours | |
Oct-21 | |
Oct-21 | |
Oct-21 | |
Oct-20 | |
Oct-17 | |
Oct-17 | |
Oct-17 | |
Oct-16 | |
Oct-16 | |
Oct-15 | |
Oct-15 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite